spacer
home > ict > autumn 2016 > the patient chronicle
PUBLICATIONS
International Clinical Trials

The Patient Chronicle

Electronic health records (EHRs) are longitudinal, digital registers of patient health information that can include patient demographics, progress notes, medications, vital signs, past medical history, immunisations, laboratory data and radiology reports (1). Every patient interaction with a healthcare provider produces data; EHRs can store this information and capture the health of a patient across time. The widespread adoption of EHRs is generating comprehensive quantitative and qualitative datasets that could provide many advantages for patients and healthcare companies, but that are also associated with certain obstacles.

Potential Gains


EHRs offer numerous benefits that could possibly transform healthcare, and significantly enhance clinical decisions and patient outcomes. They strengthen healthcare delivery, reduce costs and enable clinicians to make well-informed treatment decisions quickly and safely.

For example, patient safety might be improved when EHRs maintain a record of medications and allergies. When data are accurately inputted into an EHR, the clinician is then able to check for problems such as potential prescribing of conflicting drugs. This lowers the incidence of medical errors, as well as avoids unnecessary patient concerns and additional treatment costs that might be incurred in the event of drug interactions (2). The utilisation of EHRs could also identify patients who are due for preventative visits and screenings, meaning earlier diagnosis and possible hindrance of disease development. In the US, for instance, EHRs can provide these benefits through the following functionalities: clinical decision support tools, computerised physician order entry systems and health information exchange (3).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Professor Martin Gibson is Chief Executive of NorthWest EHealth, Director of the National Institute for Health Research in Clinical Research for Greater Manchester and Research and Informatics Director for the Greater Manchester Academic Health Science Network. He is also a Consultant Doctor specialising in diabetes and lipid disorders at the Salford Royal NHS Foundation Trust, where he was formerly R&D Director of both the acute and primary care trusts.
spacer
Martin Gibson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PPMA Show 2021 celebrates great success as it leads the way to build back business

The UKs largest processing and packaging machinery event returned to the NEC, Birmingham (28-30 September) following the cancellation of the 2020 Show. Hailed as a great success by exhibitors and visitors, over 250 exhibitors and 1,250 brands showcased the latest innovations in smart manufacturing, processing equipment and packaging solutions.
More info >>

White Papers

eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials

Clinical Ink

Unlike traditional electronic data capture (EDC), SureSource, Clinical Inks eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement